Open main menu
Home
Random
Donate
Recent changes
Special pages
Community portal
Preferences
About Stockhub
Disclaimers
Search
User menu
Talk
Contributions
Create account
Log in
Editing
Nuance Communications, Inc.
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Competition == The AI in healthcare market is filled with promising prospects. Companies are utilising a range of technological advancements to enhance patient outcomes and decrease treatment expenses. The increasing elderly population worldwide, lifestyle changes, and higher incidence of chronic illnesses have led to a significant rise in the need for early disease diagnosis and better disease comprehension. To meet these demands, healthcare systems are extensively adopting and incorporating Artificial Intelligence (AI) and machine learning (ML) algorithms. Some key players in this field who are competitors for Nuance and now Microsoft too after the acquisition are: * IBM Corporation - In April 2023, IBM Corporation partnered with Moderna Inc. to integrate AI and quantum computing into mRNA development. The collaboration involves investments in generative AI to enhance product design, utilising the MoLFormer AI model to optimise mRNA and lipid nanoparticles. * NVIDIA Corporation - In March 2023, NVIDIA Corporation and Medtronic Plc. joined forces with Cosmo Pharmaceuticals to advance AI capabilities in colonoscopy procedures. Medtronic plans to integrate NVIDIA's AI technology into its GI Genius Intelligent Endoscopy Module, creating the GI Genius AI Access platform for healthcare AI innovation. * Intel Corporation * GE HealthCare * BenevolentAI
Summary:
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Stockhub:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)